KLTO (Klotho Neurosciences) FCF Yield % : -33.61 (As of Mar. 28, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Klotho Neurosciences's Trailing 12-Month Free Cash Flow is $-2.13 Mil, and Market Cap is $6.32 Mil. Therefore, Klotho Neurosciences's FCF Yield % for today is -33.61%.

The historical rank and industry rank for Klotho Neurosciences's FCF Yield % or its related term are showing as below:

KLTO' s FCF Yield % Range Over the Past 10 Years
Min: -33.64 Med: 0 Max: 0
Current: -33.61

KLTO's FCF Yield % is ranked worse than
65.53% of 1500 companies
in the Biotechnology industry
Industry Median: -14.52 vs KLTO: -33.61

Klotho Neurosciences's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Klotho Neurosciences FCF Yield % Historical Data

The historical data trend for Klotho Neurosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences FCF Yield % Chart

Klotho Neurosciences Annual Data

Trend

Dec21

Dec22

FCF Yield %

Klotho Neurosciences Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Sep23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-9.33	-30.84

Competitive Comparison of Klotho Neurosciences's FCF Yield %

For the Biotechnology subindustry, Klotho Neurosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klotho Neurosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Klotho Neurosciences's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Klotho Neurosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Klotho Neurosciences's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.725	/	0
	=	N/A%

Klotho Neurosciences's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.073	*	4	/	13.917288
	=	-30.84%

Klotho Neurosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Klotho Neurosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Klotho Neurosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Klotho Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

13576 Walnut Street, 12th Floor, Omaha, NE, USA, 68144

Website

https://www.klothoneuro.com

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.